Table 1 Frequency of phenotypes in NIH and NHANES populations and mean lipid values for NIH population
From: A new phenotypic classification system for dyslipidemias based on the standard lipid panel
Phenotypes | NIH (N = 11,365) | NHANES (N = 13,086) | TC | TG | HDL-C | LDL-C4 | NonHDL-C | ApoB | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NL | 1600 (14.1%)1 | 1004 (7.71%)1 | 126(112–139)2 | G3 | 84 (57–110) | H | 53 (40–65) | B | 56 (49–64) | G | 73 (65–81) | G | 63 (55–70) | G |
NM | 7455 (65.6%) | 8742 (66.8%) | 180 (160–201) | E | 91 (66–117) | G | 56 (45–67) | A | 106 (89–123) | E | 124 (106–143) | E | 94 (82–106) | E |
NH | 370 (3.3%) | 703 (5.4%) | 251 (239–262) | C | 104 (80–128) | F | 58 (49–68) | A | 172 (165–178) | C | 192 (185–199) | C | 137 (129–144) | C |
I | 20 (0.2%) | 0 (0%) | 121 (113–128) | FG | 577 (535–618) | B | 20 (12–29) | F | −15 (−26--4) | I | 100 (93–107) | F | 80 (68–92) | F |
IIa | 166 (1.5%) | 205 (1.6%) | 313 (280–346) | A | 108 (76–139) | F | 56 (46–66) | AB | 235 (206–265) | A | 257 (230–283) | A | 176 (158–194) | A |
IIb | 153 (1.3%) | 274 (2.1%) | 312 (279–345) | A | 292 (230–354) | C | 47 (38–56) | C | 206 (181–231) | B | 265 (236–293) | A | 181 (162–200) | A |
IVa | 483 (4.2%) | 391 (3%) | 141 (123–159) | F | 245 (203–286) | E | 36 (27–45) | E | 56 (39–72) | G | 105 (91–119) | F | 80 (68–92) | F |
IVb | 940 (8.3%) | 1642 (12.5%) | 206 (187–225) | D | 260 (208–312) | D | 39 (32–46) | D | 115 (97–132) | D | 167 (150–183) | D | 120 (107–133) | D |
V | 144 (1.3%) | 123 (0.9%) | 261 (209–314) | B | 686 (580–792) | A | 32 (24–40) | EF | 92 (43–142) | F | 229 (182–277) | B | 144 (114–173) | B |
VI | 34 (0.3%) | 2 (0%) | 50 (43–58) | H | 16 (13–19) | I | 28 (24–32) | EF | 19 (15–23) | H | 22 (18–25) | H | 29 (25–34) | H |